Faricimab lacks proof of added benefit over comparator therapies for macular edema

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion.

Researchers uncover novel targets for treatment of schistosomiasis

The worms that cause schistosomiasis (Schistosoma mansoni) are unusual in several ways, especially the fact that male and female adults must stay paired together throughout

July 22, 2023

Misdiagnoses cost the U.S. 800,000 deaths and serious disabilities every year, study finds

Diagnostic errors — that is, overlooking a disease, or diagnosing it erroneously or late — are a known occurrence in health care, and one that

July 21, 2023

Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

October 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.